Back to universe
E
Emami
BHoldEMAMILTD · NSE · Mid Cap · FMCG Supplier
FMCG Supplier
Fetching live…
₹525
1D -0.2%1M -1.0%1Y -10%
Fundamental (RQ-100)
80
Technical (TQ-100)
40
Valuation
57
Market cap
₹23.0K Cr
Live decision ratingASell / Avoid
Fundamental score breakdown
80/100Growth Quality
6.4 / 20
Rev 1Y 5.0%, 3Y CAGR 8.0%, 5Y CAGR 5.0%
Margin & Profitability
15.0 / 15
EBITDA 28.0%, PAT 18.0%
Return on Capital
20.0 / 20
ROCE 36.0%, ROE 32.0%
Cash Flow Quality
13.0 / 15
OCF/EBITDA 0.85
Leverage
10.0 / 10
ND/EBITDA -0.40
Reinvestment
5.0 / 8
Capex/Sales 2.0%
Accounting
7.0 / 7
Governance
4.0 / 5
Technical score breakdown
40/100Trend Structure
8.0 / 20
↓ 200 · ↓ 50 · ↓ 20
Momentum
5.0 / 15
1Y -10.0%, 1M -1.0%
Volume Dynamics
8.0 / 15
Vol30 —%
Relative Strength
4.0 / 15
1Y -10.0%
MA Cluster
5.0 / 10
Extension
5.0 / 10
—% from 50DMA
Volatility
4.0 / 8
Price Action
1.0 / 7
-100.0% from 52W H
Business
What this company actually does
Personal care (BoroPlus, Navratna, Fair & Handsome).
Stores
—
Dark stores
—
Cities
—
Listed status
Listed
Format exposure
How direct is this play?
Primary formatFMCG Supplier
Exposure typeMeaningful
Revenue visibilityHigh
Operating leverage stageMaturity
Policy beneficiaryNone
Data confidenceMedium
Financial snapshot
Live · green dot = live, falls back to curated
Revenue
₹3.7K Cr
Rev 1Y growth
5%
Rev 3Y CAGR
8%
EBITDA margin
28.0%
PAT margin
18.0%
ROE
32%
ROCE
36%
OCF/EBITDA
0.85
Net Debt/EBITDA
-0.4
Financial statements
Multi-year P&L, balance sheet, cash flow — scraped live from Screener.in
Fetching from Screener.in…
Loading…
Valuation
Live multiples + retail-specific (curated)
P/E
38
Forward P/E
32
EV/EBITDA
25
EV/Sales
6.0
P/B
10.0
FCF Yield
2.4%
Mid-range valuation. Watch incremental ROCE.
Investment thesis
AI-generated · always cite sources before acting
Bull
Long-runway TAM with structural tailwinds.
Base
Earnings growth of ~9% over the next 3 years assuming margins hold. Multiple compression risk if growth slows; multiple expansion possible if FMCG Supplier GMV outperforms.
Bear
Format-level risk: regulation, gig-cess, or competitive pressure compress contribution margin.
Variant perception
Consensus views Emami as a decent operator. Our differentiated take: the current multiple already prices in mid-cycle outcomes.
Key monitorables
- Quarterly EBITDA margin trajectory
- Revenue growth vs management guidance
- Capex vs store/dark-store adds
- Promoter holding and ESOP dilution
Peers
Same primary format · sorted by market cap